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Density of human bone marrow stromal cells regulates
commitment to vascular lineages
Jemima L. Whyte, Stephen G. Ball, C. Adrian Shuttleworth,
Keith Brennan, Cay M. Kielty⁎Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, University of Manchester, UKReceived 12 October 2010; received in revised form 4 February 2011; accepted 9 February 2011
Available online 17 February 2011Abstract Mechanisms underlying the vascular differentiation of human bone marrow stromal cells (HBMSCs) and their
contribution to neovascularisation are poorly understood. We report the essential role of cell density-induced signals in
directing HBMSCs along endothelial or smooth muscle lineages. Plating HBMSCs at high density rapidly induced Notch signaling,
which initiated HBMSC commitment to a vascular progenitor cell population expressing markers for both vascular lineages.
Notch also induced VEGF-A, which inhibited vascular smooth muscle commitment while consolidating differentiation to
endothelial cells with cobblestone morphology and characteristic endothelial markers and functions. These mechanisms can be
exploited therapeutically to regulate HBMSCs during neovascularisation.
© 2011 Elsevier B.V. All rights reserved.Abbreviations: αSMA, smooth muscle alpha actin; DAPT, N-[N-
(3,5-difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester;
DMSO, dimethyl sulfoxide; ECs, endothelial cells; EDTA, ethylene-
diaminetetraacetic acid; HES-1, hairy enhancer of split-1; HUVECs,
human umbilical vein endothelial cells; LDL, low density lipoprotein;
HBMSCs, human bone marrow stromal cells; PECAM-1, platelet
endothelial cell adhesion molecule-1 (CD31); SM-MHC-1, vascular
smooth muscle myosin heavy chain 1; VCAM-1, vascular cell adhesion
molecule; VE-cadherin, vascular endothelial cadherin; VEGF, vas-
cular endothelial growth factor; VEGFR1, vascular endothelial
growth factor receptor 1; VEGF-I, VEGF neutralization antibody;
VEGFR-I, VEGFR signaling inhibitor; vSMC, vascular smooth muscle
cell; vWF, Von Willebrand factor.
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Human bone marrow stromal cells (HBMSCs) have therapeutic
potential in cell transplantation and tissue engineering. In addition
to their anti-inflammatory and immunomodulatory characteristics
(Lee et al., 2009a; Casiraghi et al., 2010), they have the capacity to
differentiate directly along skeletal and other mesenchymal
lineages (Pittenger et al., 1999; Augello and De Bari, 2010). A
major challenge now is to define the mechanisms that regulate their
differentiation along vascular endothelial cell (EC) and smooth
muscle cell (vSMC) lineages.
Cultured HBMSCs typically possess some characteristics of
synthetic proliferative vSMCs. In particular, they express the early
contractile marker smooth muscle alpha actin (αSMA), as well as
calponin and smoothelin-B (Ball et al., 2004). Stimuli shown to
induce the differentiation of HBMSCs towards vSMCs include
mechanical strain (Kurpinski et al., 2006), inhibition of DNA
methylation (Wakitani et al., 1995), and transforming growth factor
(TGF)β and Notch signaling (Kurpinski et al., 2010). Other studies.
239High stromal cell density induces vascular commitmenthave indicated that HBMSCs have the potential to differentiate
towards EC lineages (Al-Khaldi et al., 2003; Bai et al., 2009; Chen et
al., 2009; Chung et al., 2009; Lozito et al., 2009; Ohata et al., 2009;
Oswald et al., 2004; Siekmann et al., 2008; Wu et al., 2005a; Xu et
al., 2009; Yue et al., 2008; Zhang et al., 2008). In many of these
studies, HBMSCs exposed over days to exogenous vascular endothe-
lial growth factor (VEGF-A) showed evidence of differentiation
towards ECs. However, HBMSCs do not always express vascular
endothelial growth factor receptors (VEGFRs) (Chen et al., 2009;
Oswald et al., 2004; Ball et al., 2007). Notch signaling has also been
shown to direct HBMSCs towards an EC fate when activated
experimentally using recombinant ligands, chemical exposure, or
expression constructs (Ohata et al., 2009; Siekmann et al., 2008; Xu
et al., 2009; Zhang et al., 2008).
Notch and VEGF signaling coordinate endothelial cell activity
during vascular development, arterio-venous specification, vessel
branching and endothelial tip cell formation (Gridley, 2007; Lawson
et al., 2001; Boulton et al., 2008; Roukens et al., 2010; Jakobsson et
al., 2010). We have investigated how these signaling mechanisms
also direct the commitment of HBMSCs toward vascular ECs or
vSMCs. We report that plating HBMSCs at high density rapidly
stimulates Notch signaling, which induces vascular progenitor cells
with the capacity to give rise to either EC or vSMC lineages. VEGF-A is
not essential for the initiation of HBMSC differentiation to ECs but
regulates the fate decision between EC and vSMC lineages. These
mechanistic insights may be exploited in therapeutic applications of
HBMSCs.Results
HBMSCs plated and cultured at high density
differentiated toward endothelial cells
Cell density can regulate the morphology and differentiation of
HBMSCs (Ball et al., 2004; McBeath et al., 2004). Using HBMSCs which
could be induced to differentiate toward adipocytes, osteocytes, or
chondrocytes (Supplementary Fig. S1), we studied the impact of
plating HBMSCs at high cell density on their differentiation toward
ECs, monitoring morphology (Fig. 1A), specific functional properties
(Fig. 1B), and expression of a panel of characteristic endothelial
markers (Figs. 1C and D).
HBMSCs plated at high density and cultured for 14 days (Fig. 1AIII)
adopted a cobblestone-like morphology comparable to that of
human umbilical vein endothelial cells (HUVECs) (Fig. 1AIV),
whereas HBMSCs cultured under standard conditions for 48 h
(Fig. 1AI), or at low cell density for 14 days (Fig. 1AII), maintained
a spindle-shaped morphology.
HBMSCs plated at high density and cultured for 28 days displayed
low density lipoprotein (LDL) uptake in approximately 53% of cells
analysed (Fig. 1BIII), and VCAM-1 was also induced in response to
TNFα (Fig. 1BVI). In contrast, HBMSCs cultured under standard
conditions for 48 h did not display LDL uptake (Fig. 1BII) or VCAM-1
induction in response to TNFα (Fig. 1BV). As expected, HUVECs as
positive control cells exhibited EC functional characteristics of LDL
uptake (Fig. 1BI) and induction of VCAM-1 in response to TNFα
(Fig. 1BIV).
The distribution of the EC markers VE-cadherin, PECAM-1, vWF,
and VEGFR1 in HBMSCs was examined by immunofluorescence
microscopy. HBMSCs plated at high density and cultured for 14 or
28 days displayed prominent EC marker immunostaining (Figs. 1CIII
and VI, DIII and VI). In contrast, HBMSCs cultured under standard
conditions for 48 h displayed little or no immunofluorescence for the
EC markers examined (Figs. 1CII and V, DII and V). As expected,
HUVECs as positive control cells expressed the characteristic
markers VE-cadherin (Fig. 1CI), PECAM-1 (Fig. 1CIV), vWF
(Fig. 1DI), and VEGFR1 (Fig. 1DIV).High density HBMSCs expressed endothelial and
smooth muscle cell markers by 24 h
As plating at high cell density for up to 28 days induced HBMSCs to
adopt an endothelial phenotype (Fig. 1), we further investigated the
time scale of these cellular changes by examining the expression of
vascular cell markers following HBMSC culture at high density for 24 h
and 3 days. The expression of EC (vWF, VEGFR1 and PECAM-1)
(Figs. 2A–C) and vSMC (αSMA, calponin, smoothelin-B, and SM-MHC-1)
(Figs. 2D–G) markers were analysed by immunoblot analysis.
Compared to HBMSCs cultured at low density for 24 h (lane 1),
culturing HBMSCs at high density (lane 2) not only induced the
expression of the EC markers vWF (Fig. 2A), VEGFR1 (Fig. 2B), and
PECAM-1 (Fig. 2C), butmarkedly up-regulated the expression of vSMC
markers α-SMA (Fig. 2D), calponin (Fig. 2E), smoothelin-B (Fig. 2F),
and SM-MHC-1 (Fig. 2G). To determine whether individual HBMSCs
were expressing both EC and vSMC markers, double-labeling
immunofluorescence analysis was conducted (Fig. 2H). This analysis
clearly demonstrated that individual HBMSCs were coexpressing EC
and vSMCmarkers following culture at high cell density for 24 h. Thus,
both EC and vSMC markers were enhanced within 24 h of plating
HBMSCs at high density, indicating a vascular progenitor phenotype
with potential to form ECs or vSMCs.
High density HBMSCs enhanced endothelial markers
but down-regulated smooth muscle cell markers by
3 days
HBMSC expression of vascular markers was further examined after
3 days. Compared to HBMSCs cultured at low density, the level of
VEGF-A secreted by HBMSCs at high cell density, normalised against
corresponding β-actin levels, was significantly increased over a 3-day
period (Fig. 3A). This enhanced VEGF-A secretion also coincided with a
significant increase in the expression of EC markers (Figs. 3B and C);
however, in comparison, expression of vSMC markers SM-MHC-1
(Fig. 3D) and smoothelin-B (Fig. 3E) dramatically decreased by
3 days. Thus, sustained culture of HBMSCs plated at high density
promoted EC differentiation but inhibited vSMC differentiation.
Notch signaling induced vascular progenitor cells
and VEGF-A secretion
Notch signaling is known to regulate vascular remodeling (Gridley,
2007). To investigate whether signaling through Notch receptors
controlled the density-dependent differentiation of HBMSCs toward
vascular phenotypes, Notch signaling molecules were examined up
to 3 days after plating HBMSCs at high density (Fig. 4). The Notch
transcription factor HES-1 was not detected in HBMSCs cultured at
low cell density, but was rapidly induced within 24 h of plating
HBMSCs at high density, and levels remained high during 3 days
culture (Fig. 4A). To investigate whether Notch signaling may
contribute to inducing vascular progenitor cells within 24 h, HBMSCs
plated at low density or high density were immunostained for Notch
receptors 1–4. Only the high density HBMSCs strongly expressed
Notch receptors 1, 2, and 3, (Supplementary Fig. S2), while Notch
receptor 4 was not detected (not shown). This result was confirmed
by qPCR and immunoblot analysis (not shown).
DAPT is a chemical inhibitor of Notch signaling that inhibits the
transcription of target genes, including HES-1 (Boulton et al., 2008)
(Supplementary Fig. S3A). HBMSCs plated at high density were
therefore treated with DAPT for 24 h, and then the expression of
markers for EC and vSMC were determined by immunoblot analysis
(Figs. 4B–D). HBMSCs plated at high density and cultured in the
presence of DAPT showed a significant decrease in VEGFR1 and vWF
(Figs. 4B and C) and SM-MHC-1 (Fig. 4D) compared to DMSO-treated
Figure 1 HBMSCs plated and cultured at high density differentiated toward functional ECs. To determine whether HBMSCs plated and
cultured at high density differentiated toward EC over time, their morphology, EC functional properties, and expression of EC markers
were determined. (A) Representative phase contrast images of (I) HBMSCs under standard culture conditions (MSC-St) for 48 h, (II) HBMSCs
cultured at low density (HBMSC-L) for 14 days, or (III) HBMSCs cultured at high density (HBMSC-H) for 14 days. (IV) HUVECs under standard
culture conditions were used as a positive cellular control. For culture conditions, see Materials and methods. Images were
obtained using an Olympus (CK X41) microscope (4x objective). Inserts represent an enlarged region of each image. Scale
bars=200 μm. (B) (I–III) Immunofluorescence analysis showing DiI-Ac-LDL uptake in (I) HUVECs, (II) HBMSCs under standard culture
conditions (HBMSC-St) for 48 h, and (III) HBMSCs cultured at high density (HBMSC-H) for 28 days. DiI-Ac-LDL uptake (red), DAPI
(blue). Images obtained using an Olympus upright widefield fluorescence (BX51) microscope (20x objective). Scale bars=20 μm. (IV–
VI) Immunofluorescence analysis of VCAM-1 in cells stimulated with 10 μg/ml TNFα for 24 h. (IV) HUVECs under standard culture
conditions for 48 h, (V) HBMSCs under standard culture conditions (HBMSC-St) for 48 h, and (VI) HBMSCs at high density (HBMSC-H)
for 28 days. VCAM-1 (green), DAPI (blue). Images were obtained using a Nikon C1 upright confocal microscope (60x objective). Scale
bars=20 μm. (C,D) Immunofluorescence analysis of VE-cadherin, PECAM-1, vWF, and VEGFR1 expression in (I, IV) HUVECs under standard
culture conditions for 48 h, (II, V) HBMSCs under standard culture conditions for 48 h, or (III, VI) HBMSCs cultured at high density (HBMSC-H)
for (C) 28 days or (D) 14 days. VE-cadherin, PECAM-1, vWF, and VEGFR1 (green), phosphorylated VEGFR1 (red), DAPI (blue). Images were
obtained using a Nikon C1 upright confocal microscope (60x objective) (C, I–VI; and D, IV–VI) or using an Olympus IX71 Deltavision
microscope (40x objective) (D, I–III). Scale bars=10 μm. White arrows highlight specific regions of localised immunoreactivity.
Representative images from two independent experiments.
240 J.L. Whyte et al.control HBMSCs. In addition, the level of VEGF-A secreted by DAPT-
treated HBMSCs at high density for 24 h, normalised against
corresponding β-actin levels, was also significantly inhibited
(Fig. 4E). Thus, Notch signaling enhanced VEGF-A secretion and
induced a vascular progenitor cell state.
To examine whether Notch receptors 1–3 were involved in
inducing vascular progenitor cells and stimulating VEGF-A secretion,
siRNA knockdown was performed. The efficacy of each siRNA
knockdown compared to scrambled siRNAs was confirmed by
immunoblot analysis (Supplementary Fig. S3B). The specificity of
each siRNA Notch receptor knockdown was confirmed by reprobingthe blots for a nontarget Notch receptor, which revealed unchanged
protein levels in each case (Supplementary Fig. S3B). Knockdown of
Notch receptors was therefore used to investigate which Notch
receptors were involved in regulating the expression of vascular
markers in HBMSCs plated at high density for 24 h (Figs. 4F–I).
Knockdown of Notch receptor 1, 2, or 3 demonstrated a significant
decrease both in VEGFR1 expression (Fig. 4F) and in VEGF-A
secretion (Fig. 4I). Knockdown of Notch receptor 1 or 2 significantly
inhibited vWF expression (Fig. 4G, lanes 2 and 3), while knockdown
of Notch receptors 1 or 3 significantly inhibited SM-MHC-1 expression
(Fig. 4H, lanes 2 and 4).
241High stromal cell density induces vascular commitmentThus, Notch signaling activated by plating HBMSCs at high cell
density is required for induction of vascular progenitor cells and
commitment toward ECs.
Notch activation stimulated HBMSCs at low density
to express EC markers
We examined whether activation of Notch signaling could induce the
vascular potential of HBMSCs plated and cultured at low cell density.
Notch signaling can be activated by treating cells with cation
chelators, which cause the rapid shedding of the Notch extracellular
domain, thereby increasing Notch receptor 1 intranuclear staining
and transcription of a nuclear mediator of Notch signaling (Rand et
al., 2000; Aster et al., 1999; Rand et al., 1997). HBMSCs plated at
high density and cultured for 24 h in the presence of 5 mM EDTA
displayed an increase in HES1, demonstrating the efficacy of EDTA
treatment (Supplementary Fig. S3C). While neither VEGFR1 nor vWF
were detected when HBMSCs were plated at low cell density and
cultured for 24 h in the absence of EDTA (Figs. 5A and B, lanes 1),
HBMSCs cultured at low cell density in the presence of EDTA
expressed both VEGFR1 (Fig. 5A, lane 2) and vWF (Fig. 5B, lane 2).
Thus, activation of Notch signaling by EDTA exposure induced the
expression of EC markers that would otherwise only be expressed by
HBMSCs plated at high density.
To confirm that HBMSCs plated at low density and cultured for
24 h could be induced to up-regulate expression of vWF by Notch
activation, HBMSCs at low cell density were exposed to the Notch
ligand Jagged-1 (Fig. 5C). Immunoblot analysis revealed that,
compared to unstimulated HBMSCs (Fig. 5C, lane 1), exposure toFigue 2 HBMSCs plated at high density and cultured for 24 h expre
density for 24 h were examined for the expression of vascular cell m
density for 24 h to determine the expression of markers for EC and v
(F) smoothelin-B (SMTH), and (G) SM-MHC-1 in HBMSCs cultured at l
Membranes were reprobed with β-actin as loading controls. PECAM
volumes of protein lysate were immunoblotted for β-actin as loadin
shown for each analysis. (H) Double-labeling immunofluorescence a
markers following culture at high cell density for 24 h. vSMC marker
(I) vWF, (II) VEGFR1, and (III) PECAM-1 (green); DAPI (blue). The isotyp
C1 upright confocal microscope (60x objective). Scale bars represent
and vSMC markers. Representative images obtained from two indepenJagged-1 induced HBMSCs at low cell density to enhance vWF
expression (Fig. 5C, lane 2).
Thus, Notch signaling was sufficient to stimulate EC marker
expression in HBMSCs at low cell density.
VEGF-A promoted EC differentiation but inhibited
vSMC differentiation
Since HBMSCs plated at high density for 24 h significantly increased
their VEGF-A secretion, which was Notch dependent (Fig. 4E),
experiments were conducted to determine if Notch-induced VEGF-A
inhibited differentiation toward vSMCs. When HBMSCs that had been
plated at high cell density and cultured for 24 h in the presence of a
VEGF neutralisation antibody (designated VEGF-I) (Supplementary
Fig. S3D), there was a significant up-regulation of SM-MHC-1 (Fig. 6A)
and desmin expression (data not shown). To confirm that VEGF-A
suppressed SM-MHC-1 expression, VEGF siRNA knockdown was
performed (Supplementary Figs. S3E and F). VEGF-A knockdown
was shown significantly to up-regulate SM-MHC-1 (Fig. 6B), indicat-
ing that VEGF-A was inhibiting expression of this definitive vSMC
contractile marker.
VEGF-A has been implicated in directing HBMSC differentiation
toward ECs (see Introduction). However, exposure to exogenous
VEGF-A for 24 h did not initiate HBMSC commitment to ECs
(Supplementary Figs. S4A–C). To investigate whether, over a longer
time frame, VEGF-A influenced HBMSC commitment to ECs, HBMSCs
were plated at high density and cultured for 14 days in the absence
or presence of VEGF-I, or a chemical inhibitor of VEGF signaling
(designated VEGFR-I) (Supplementary Fig. S3G). In the presence ofssed EC and vSMC markers. HBMSCs plated and cultured at high
arkers. (A–G) Immunoblot analysis of HBMSCs cultured at high
SMC. (A) vWF, (B) VEGFR1, (C) PECAM-1, (D) αSMA, (E) calponin,
ow density for 24 h (lane 1) or at high density for 24 h (lane 2).
-1 was immunoprecipitated prior to immunoblotting and equal
g controls. Representatives of two independent experiments are
nalysis to detect individual HBMSCs coexpressing EC and vSMC
s (I) αSMA, (II) calponin, and (III) smoothelin-B (red); EC markers
e control IgG1 is also depicted. Imageswere obtained using aNikon
20 μm. White arrows highlight individual HBMSCs coexpressing EC
dent experiments are shown.
Figure 3 High density HBMSCs expressed increased endothelial cell markers but reduced smooth muscle cell markers, by 3 days. The
levels of vascular cell markers were determined in HBMSCs plated and cultured at high density for 3 days. (A) ELISA assay of VEGF-A
derived from medium taken from HBMSCs cultured at low density for 24 h, or at high cell density up to 3 days, normalised against
corresponding β-actin levels. (B–E) Immunoblot analysis of (B) vWF, (C) VEGFR1, (D) SM-MHC-1, and (E) smoothelin-B (SMTH) in
HBMSCs cultured at low density (HBMSC-L) for 24 h or at high cell density up to 3 days. Pixel density was normalised to β-actin and
plotted as bar graphs. * Pb0.05 compared to HBMSCs cultured after plating at low cell density.
242 J.L. Whyte et al.VEGF-I or VEGFR-I, HBMSCs showed a significant reduction in VEGFR1
expression (Fig. 6C) and VE-cadherin expression (Fig. 6D). Thus,
although VEGF-A is not sufficient to initiate HBMSC differentiation to
ECs, it enhances EC differentiation in sustained high cell density
cultures.
To confirm that VEGF-A stimulated VEGFR1 expression over
14 days, HBMSCs plated at high density were exposed to recombinant
VEGF-A. Following culture of HBMSCs at high density in the presence
of VEGF-A, VEGFR1 transcript (Fig. 6E) and protein expression
(Fig. 6F) were significantly enhanced over this time frame. Thus,
Notch-induced VEGF-A supports EC differentiation in sustained high
cell density cultures.Tubule formation by HBMSCs precultured at high
density
HBMSCs that had been precultured for up to 28 days at high cell
density were cultured on Matrigel and exposed to chick chorioal-
lantoic membranes (CAM). Both control and high density cultured
HBMSCs readily formed widespread tubule networks on Matrigel, but
only high density cultured HBMSCs expressed EC markers (Fig. 7A).
While exposure to the CAM induced control HBMSCs to express EC
markers (vWF, VE-cadherin, PECAM-1, and VEGFR2), in comparison,
HBMSCs cultured at high density produced more abundant EC marker
expression, formed more robust tubules (Fig. 7B), and were found to
induce significantly larger blood vessels in the CAM (Fig. 7C).We also evaluated the ability for HBMSCs precultured at high
density to retain their EC phenotype when subcultured at low cell
density. HBMSCs cultured at high density for 28 days were
trypsinised and subcultured at low cell density for 7 days, and then
their level of VEGFR1 and vWF expression was determined by
immunoblot analysis (Supplementary Fig. S4D). Compared to HBMSCs
cultured at high density for 28 days, those subsequently subcultured
at low density for 7 days expressed only slightly lower levels of
VEGFR1 and vWF, suggesting that the EC phenotype was maintained.
Together, these data show that coordinated Notch and VEGF-A
signals direct the differentiation of HBMSCs toward ECs.Discussion
Defining the mechanisms that regulate HBMSC differentiation along
vascular cell lineages will advance opportunities to exploit them in
cell-based and neovascularisation therapies. While HBMSC differ-
entiation toward vSMCs involves mechanical strain (Kurpinski et al.,
2006), DNA methylation changes (Wakitani et al., 1995), and TGFβ
and Notch signaling (Kurpinski et al., 2010), mechanisms underlying
the differentiation of HBMSCs to ECs remain incompletely under-
stood but largely attributed to VEGF-A. In this study, the inductive
effect of cell contact has been identified as a potent trigger to
vascular differentiation (Fig. 8). Cell contact-activated Notch
signaling initially induced vascular progenitor cells with EC and
vSMC characteristics. Subsequent differentiation toward ECs, but
243High stromal cell density induces vascular commitmentnot vSMCs, was regulated by Notch-induced VEGF-A. Thus,
coordinated Notch and VEGF-A signaling directs HBMSCs toward
ECs.
Notch receptors are critical for vascular development and
function (Gridley, 2007; Lawson et al., 2001; Boulton et al., 2008;
Roukens et al., 2010; Jakobsson et al., 2010). In this study, Notch
receptors 1–3 were directly implicated in the induction of vascular
progenitor status in the HBMSCs cultured at high density, and thus
contribute to vascular commitment. Although Notch 4 can be
expressed in vascular cells (Wu et al., 2005b), we did not detect
Notch 4 either at 24 h after plating at high density or by 28 days (not
shown). Thus, Notch 4 appears not to be necessary for the
differentiation of HBMSCs to ECs.Figure 4 Notch signaling stimulated the formation of the vascular p
regulating the expression of vascular cell markers in HBMSCs at high
HBMSCs cultured at low density (lane 1) for 24 h or at high density up t
regulated the expression of vascular cell markers and VEGF-A, their pro
by DAPT treatment (50 μM), with DMSO used as a diluent control. Immu
density HBMSCs cultured in the presence of DAPT (lanes 1) or DMSO (la
graphs. * Pb0.05 compared to HBMSCs plated at high density in the pr
medium taken from HBMSCs cultured at low cell density (L) or high cell
normalised against corresponding β-actin levels. * Pb0.05 compared to
of DMSO only. (F–I) To confirm that Notch signaling induced vascular m
receptors 1, 2, or 3 (N1–N3)was performed. Immunoblot analysis of (F)
after plating at high cell density, following transfection with scramble
(lanes 2–4).Membraneswere reprobedwithβ-actin as loading controls
* Pb0.05 compared to scrambled control-transfected HBMSCs. Data are
VEGF-A derived from medium taken from HBMSCs cultured at high ce
against corresponding β-actin levels. * Pb0.05 and # Pb0.1 comparedDensity-dependent Notch signaling rapidly induced a vascular
progenitor cell state characterised by expression of EC and vSMC
markers. Since VEGFR1 is not endothelial-specific, despite being a
major EC product (Supplementary Fig. S5), several other endothelial
markers were utilized including VEGF-A, VE-cadherin, PECAM-1, and
vWF. We found that VEGF-A was strongly induced by Notch, which in
turn stimulated commitment of progenitor HBMSCs along the EC
lineage. Interestingly, exposure to exogenous VEGF-A at standard
density over 24 h was not sufficient to induce HBMSCs to express EC
markers (Supplementary Fig. S4). Therefore, VEGF-A is not sufficient
to initiate HBMSC differentiation to ECs, although it supports
differentiation in sustained high density cultures. In vivo studies
have documented how VEGF can disrupt vSMC function, ablatingrogenitor cell and VEGF-A secretion. The role of Notch signaling in
cell density was determined. (A) Immunoblot analysis of HES-1 in
o 3 days (lanes 2–4). (B–D) To investigate whether Notch signaling
tein levels were determined following inhibition of Notch signaling
noblot analysis of (B) VEGFR1, (C) vWF, or (D) SM-MHC-1 from high
nes 2). Pixel density was normalised to β-actin and plotted as bar
esence of DMSO only. (E) ELISA assay of VEGF-A derived from the
density (H) in the presence of DMSO as a diluent control, or DAPT,
HBMSCs cultured after plating at high cell density in the presence
arker expression and VEGF-A secretion, siRNA knockdown of Notch
VEGFR1, (G) vWF, and (H) SM-MHC-1 fromHBMSCs cultured for 24 h
d (Scr) controls (lane 1) or siRNAs for Notch receptors 1, 2, and 3
. Pixel densitywas normalised toβ-actin andplotted as a bar graph.
representative of two independent experiments. (I) ELISA assay of
ll density following Notch receptor siRNA knockdown, normalised
to scrambled control HBMSCs.
Figure 5 Notch activation stimulated HBMSCs at low density
to express EC markers. To determine whether experimental
activation of Notch could induce vWF and VEGFR1 protein
expression in HBMSCs plated at low density and cultured for
24 h, HBMSCs were treated with Notch activators. (A,B)
Immunoblot analysis of (A) VEGFR1 or (B) vWF protein expression
from HBMSCs cultured after plating at low density (L) (lanes 1
and 2), or high cell density (H) (lanes 3 and 4), in the absence (−)
(lanes 1 and 3) or presence (+) (lanes 2 and 4) of 5 mM EDTA. (C)
To verify that HBMSCs cultured at low density could be induced
to up-regulate vWF protein expression by activation of Notch
signaling, Notch was activated using 5 μM Jagged-1. Immunoblot
analysis of vWF protein expression in HBMSCs cultured after
plating at low density (lanes 1 and 2) or high cell density (lanes 3
and 4) in the absence (−) (lanes 1 and 3) or presence (+) (lanes 2
and 4) of 5 μM Jagged-1. Membranes were reprobed with β-actin
as loading controls. Data are representative of two independent
experiments.
244 J.L. Whyte et al.pericyte coverage and causing vessel destabilisation (Greenberg et al.,
2008). Thus, the Notch-induced VEGF-A may have inhibited HBMSC
differentiation to vSMCs while promoting HBMSC differentiation to
ECs, and tubule formation.
We investigated several functional EC features of the high density
HBMSCs. Uptake of LDL is a characteristic function of ECs, and here we
showed that HBMSCs cultured at high density effectively took up LDL,
implying an EC-like state. However, we cannot exclude that theincreased LDL uptake might, in part, reflect fat accumulation. When
the cells were plated on Matrigel or on CAM membranes, it was clear
that they not only producedmuch larger tubules but also enhanced the
expression of several ECmarkers. Taken together, these data indicate
that the high density cells were committed to the EC lineage.
Our experiments indicate that low density culture suppresses the
potential of HBMSCs to differentiate along vascular lineages.
Therefore, a double-labeling immunofluorescence approach was
used to address whether our HBMSC populations might be bipotential
with the ability to differentiate along either SMC or EC lineages.
Many cells were found to express both vSMC and EC markers, so it
was clear that both lineages can be induced in the same cells over an
initial 24 h after plating at high density. However, there may be
some heterogeneous potential within our HBMSC populations.
HBMSCs are known to have therapeutic potential for tissue
remodeling and repair. Being multipotent, they can not only
differentiate along a range of lineages, they can also enhance
tissue repair by secreting anti-inflammatory factors (Lee et al.,
2009b). Their culture conditions can affect their phenotypic status;
for example, culture in 3D spheres was recently shown to enhance
the expression of anti-inflammatory molecules (Bartosh et al.,
2010). In this study, we have demonstrated that it is possible to
control their vascular differentiation in vitro, through regulating
plating density and cell–cell contact. High density triggers EC
differentiation by rapid induction of Notch signaling which in turn
up-regulates VEGF-A, a growth factor that consolidates EC
differentiation. These high density in vitro conditions may mirror
extensive cell contact areas in EC monolayers in vivo. Our study,
which has defined mechanisms of vascular differentiation of
HBMSCs, provides new opportunities to regulate HBMSCs in
therapeutic neovascularisation.
Conclusion
This study has highlighted the coordinated role of cell density-
dependent Notch signaling and Notch-induced VEGF-A in directing
the vascular fate of HBMSCs.
Materials and methods
Antibodies
Primary antibodies used for immunoblot and immunofluorescence
analysis were goat anti-human VEGFR1 (AF321), rabbit anti-human
phospho-VEGFR1 (Y1213) (AF4170), and goat anti-human hairy
enhancer of split-1 (HES-1) (AF3317), all from R&D Systems. Mouse
anti-human von Willebrand factor (vWF) (3H3126) (sc-73267), mouse
anti-human vascular cell adhesion molecule-1 (VCAM-1) (P3C4) (sc-
20070), mouse anti-human phosphotyrosine (PY99) (sc-7020), rabbit
anti-human smoothelin B (sc-28562), rabbit anti-human Notch 3 (m-
134) (sc-5593), and goat anti-human Notch 4 (E-12) (sc-32613) were
all from Santa-Cruz Biotechnology. Rabbit anti-human Notch 1
(C37C7), rabbit anti-human Notch 2 (8A1), mouse anti-human
platelet/endothelial cell adhesion molecule-1 (PECAM-1) (89C2)
(3528), rabbit anti-human vascular endothelial cadherin (VE-
cadherin) (2158) and rabbit anti-human VEGFR2 (55B11) (2479)
were all from Cell Signaling Technology. Mouse anti-human smooth
muscle alpha actin (αSMA) (clone 1A4), mouse anti-human calponin
(clone Calp), mouse anti-human smooth muscle myosin heavy chain 1
(SM-MHC-1) (clone SMMS-1), and negative control mouse IgG1
(X093101) were purchased from DAKO.
Growth factors and inhibitors
VEGF-A165 (298-VS) and VEGF neutralising monoclonal antibody
(clone 26503) were obtained from R&D Systems. VEGFR tyrosine
Figure 6 VEGF-A inhibited HBMSC differentiation to vSMCs but promoted EC differentiation. To determine whether secreted
VEGF-A inhibited vSMC marker expression in HBMSCs cultured at high density, the effects of blocking VEGF-A signaling was
determined. (A,B) HBMSCs cultured at high density for 24 h were (A) exposed to 1 μg/ml VEGF neutralisation antibody (VEGF-I) (lane
2) or (B) transfected with VEGF-A siRNA (lane 2), and then SM-MHC-1 expression was determined by immunoblot analysis. Untreated
HBMSCs (Cont) or scrambled (Scr) siRNA-transfected HBMSCs (lane 1) were used as respective controls. Pixel density was normalised
to β-actin and plotted as a bar graph. * Pb0.05 compared to controls. Data are representative of two independent experiments for
each analysis. (C,D) HBMSCs cultured at high density for 14 days were exposed to 1 μg/ml VEGF-I (lane 2) or 0.5 μM VEGFR tyrosine
kinase inhibitor (VEGFR-I) (C, lane 3, and D, lane 5), and then (C) VEGFR1 and (D) VE-cadherin expression was determined by
immunoblot analysis. Untreated HBMSCs were used as controls (Cont) (C, lane 1, and D, lanes 1 and 4). Pixel density was normalised
to β-actin and plotted as a bar graph. * Pb0.05 compared to untreated HBMSCs. A representative of two independent experiments
is shown in each case. (E) HBMSCs cultured at high density for 14 days were exposed to 50 ng/ml recombinant VEGF-A, and then
VEGFR transcript expression was determined by semiquantitative RT-PCR analysis. Lanes 1–2, GAPDH in untreated (control) HBMSCs.
VEGFRs 1–3 in untreated (control) HBMSCs, lanes 3–5, or following exposure to recombinant VEGF-A, lanes 6–8, respectively. Two
different primer pairs for VEGFRs 1–3 gave similar results. Red boxes denote unstimulated cells; blue boxes denote VEGF-A-
stimulated cells. (F) Immunoblot analysis of VEGFR1 protein level in untreated HBMSCs (lane 1), or following exposure to
recombinant VEGF-A for 14 days (lane 2). * Pb0.05 compared to untreated HBMSCs cultured after plating at high cell density
(HBMSC-H). In each case, fresh medium supplemented with VEGF-A or inhibitors was added to cells every 2 days.
245High stromal cell density induces vascular commitmentkinase inhibitor (KRN633) was purchased from Calbiochem. The
gamma secretase inhibitor N-[N-(3,5-difluorophenacetyl-L-alanyl)]-
S-phenylglycine t-butyl ester (DAPT) was obtained from Sigma-
Aldrich.Cell culture
Human bone marrow stromal cells were obtained from the bone
marrow of a 28-year-old female and from a 21-year-old male (Lonza).
The HBMSCs had a typical spindle-shaped morphology (SupplementaryFig. S1A), were positive for CD73, CD29, CD44, CD51, and CD105, but
negative for the haematopoietic cellmarker CD34 (Supplementary Fig.
S1B), and had the potential to differentiate toward adipocyte,
osteocyte, or chondrocyte lineages (Supplementary Fig. S1C). HBMSCs
cultured on 0.1% gelatin (Sigma-Aldrich) were maintained in basal
medium (Invitrogen) supplemented with 2% L-glutamine and 0.1%
penicillin/streptomycin. HBMSCs were cultured at 37 °C in a humid-
ified atmosphere of 20% O2, 5% CO2, and used at passage 4–5. Human
umbilical vein endothelial cells from 43-year-old and 29-year-old
females (Invitrogen)weremaintained in endothelial cell basalmedium
(Lonza), containing singleQuot supplements, and used at passage 4.
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Figure 8 Model showing how Notch signaling and VEGF-A direct the vascular differentiation of cultured HBMSCs. HBMSCs plated and
cultured at high density are induced to differentiate to an EC fate through Notch signaling and Notch-induced VEGF-A. These
mechanisms may be therapeutically applicable for neovascularisation.
247High stromal cell density induces vascular commitmentHuman dermal fibroblasts (HDFs) from a 51-year-old male, obtained
from the European Collection of Cell Cultures, were maintained in
Dulbecco's minimal essential medium (DMEM) (Invitrogen) containing
10% fetal bovine serum, 1%L-glutamine, 0.2%penicillin/ streptomycin,
and used at passage 8.
Cell plating
For standard culture conditions, cells were seeded at 70 000 cells in
9.6 cm2 at initial plating (corresponding to 70% confluence). For high
cell density experiments, HBMSCs were seeded at 100 000 cells in 9.6
cm2 at initial plating. For low density experiments, HBMSCs were
seeded at 10 000 cells in 9.6 cm2 at initial plating.
Semiquantitative and quantitative
reverse-transcription polymerase chain reaction
Total RNA was isolated from cultured cells using Trizol reagent.
Total RNA (1 μg) was reverse-transcribed and subjected to polymer-
ase chain reaction (PCR). Quantitative PCR was performed using a
SYBR green quantitative PCR core kit (Eurogentec), with each
sample run in triplicate. Data were normalized to GAPDH, and
relative expression was calculated according to the 2-[delta]CT
formula. Oligonucleotide primers for PCR were designed using
Primer3 software. Each primer pair was designed using the same
parameters (70- to 100-bp product size and Tm of 60 °C). PCR were
repeated using a second primer set (sequences not shown). Reaction
products were resolved using 2.5% ultrapure agarose (Invitrogen) gelFigure 7 Expression of endothelial markers by high density HBMSC
study the capacity of HBMSCs to form tubules, 20 000 HBMSCs cult
standard conditions (HBMSC-S) for 7 days, were seeded onto growth
Immunofluorescence analysis of (A I) PECAM-1, (A II) VE-cadherin, and
immunofluorescent images were taken using an Olympus BX51 wide
representative of two independent experiments is shown in each
environment of the chick chorioallantoic membrane (CAM) was inve
000 HBMSCs were prelabeled with DiI, seeded onto Matrigel-treated c
6 chick embryo for 48 h. (B I) Immunofluorescence analysis of vWF, us
green; DiI, red. Scale bars represent 100 μm. (B II–IV) Immunofluoresc
using a Nikon C1 upright confocal microscope (60x objective). White
Scale bars represent 20 μm. VE-cadherin, PECAM-1, or VEGFR2, green
or HBMSC-coated coverslips for 48 h. White arrows indicate where
induced larger blood vessels in the CAM. The degree of vascularisa
number of junctions, total size of complexes, and total lengths of c
each treatment, using a Nikon stereomicroscope with each ana
representative of two independent experiments is shown in each caelectrophoresis run at 100 V for 2 h in 1X TAE (Tris base, acetic acid,
EDTA) buffer containing 2.5 μl Gel Red (Biotium), and visualised
using a transilluminator.
Primer sequences
Primer sequences were as follows: GAPDH (71 bp), forward (5′-
AAGGGCATCCTGGGCTAC-3′) and reverse (5′-GTGGAGGAGTGGGT-
GTCG-3′); VEGFR1 (99 bp), forward (5′-GCGACGTGTGGTCTTACG-3′)
and reverse (5′-GGCGACTGCAAAAGTCCT-3′); VEGFR-2 (81 bp), forward
(5′-CATCCAGTGGGCTGATGA-3′) and reverse (5′-TGCCACTTCCAAAAG-
CAA–3′); VEGFR-3 (87 bp), forward (5′-GATGCGGGACCGTATCTG-3′) and
reverse (5′-ATCCTCGGAGCCTTCCAC-3′); HES1 (91 bp), forward (5′-
CCAAAGACAGCATCTGAGCA-3′) and reverse (5′-TCAGCTGGCTCA-
GACTTTCA-3′); VEGF-A (98 bp), forward (5′-CACCCATGGCAGAAGGAG-
3′) and reverse (5′-CACCAGGGTCTCGATTGG-3′); VE-cadherin (74 bp),
forward (5′-GGAGCCGAGCATGTGTCT-3′) and reverse (5′-TCTGCA-
AGGTGTGCCTGA-3′).
Immunoblot analysis
Cells were washed with phosphate-buffered saline (PBS), incubated
with lysis buffer for 15 min on ice, and then isolated. Total protein
lysates were quantitated using a bicinchoninic acid (BCA) assay
(Pierce), electrophoresed under reducing conditions using NuPAGE
4–12% Bis-Tris gels at 200 V for 2 h, and then transferred to a
nitrocellulose membrane using a NuPAGE Western transfer system
(Invitrogen). Membranes were blocked in 4% milk solids and thens on Matrigel and chick chorioallantoic (CAM) membranes. (A) To
ured at high density (HBMSC-H) for 28 days, or cultured under
factor reduced Matrigel in 0.5% serum DMEM for 48 h. (A I–III)
(A III) VEGFR2; inset depicts an enlarged region of the image. All
field microscope (20x objective). Scale bars represent 20 μm. A
case. (B) The effect of exposing HBMSCs to the angiogenic
stigated. To identify implanted cells from those of the chick, 20
overslips, and then placed in direct contact with the CAM of a Day
ing an Olympus BX51 widefield microscope (20x objective). vWF,
ence analysis of (II) VE-cadherin, (III) PECAM-1, and (IV) VEGFR2,
arrows indicate that VE-cadherin is present at the cell surface.
; DiI, red. (C) CAM vascularisation following exposure to HUVECs
the presence of HBMSCs precultured at high density (HBMSC-H)
tion was quantified with Angioquant software measuring total
omplexes. * Pb0.05. Ten representative images were taken for
lysis performed in triplicate. Scale bars represent 6 mm. A
se.
248 J.L. Whyte et al.incubated with the primary antibody overnight at 4 °C (1:500–
1:1000 dilution). Membranes were incubated with horseradish
peroxidise (HRP)-conjugated secondary antibodies (DAKO, UK) for
2 h and then developed with SuperSignal West Dura Extended
Duration Chemiluminescence (Thermo Fisher Scientific). Proteins
were visualised using KODAK X-AR film and density of bands was
determined using Gene Tools software (Syngene), and then the
corresponding loading control was normalised.
Immunofluorescence microscopy
After culturing cells on gelatin-coated 1.7 cm2 coverslips, cells
were washed with PBS and fixed in 4% paraformaldehyde for 20 min,
quenched in 0.2 M glycine (Fisher Scientific) for 20 min, and then
permeabilised in 0.5% Triton X-100 (Sigma-Aldrich) for 4 min.
Nonspecific binding was blocked with 2% fish skin gelatin solution
(Sigma-Aldrich) for 1 h, and then cells were incubated overnight at
4 °C with primary antibodies (1:50–1:100 dilution) in blocking
solution. After washing with PBS, cells were incubated with
Alexafluor secondary antibodies (Alexa-Fluor 488 conjugated or
Alexa-Fluor 546/555 conjugated (Invitrogen) (1:200 dilution) for 2 h
at room temperature. For F-actin staining, cells were also
incubated with rhodamine-conjugated phalloidin (Invitrogen)
(1:500 dilution) for 2 h at room temperature. Cells were then
washed and coverslips mounted using Prolong Gold Antifade
solution containing 4′,6-diamidino-2-phenylindole (DAPI) (Invitro-
gen). At least 20 representative images of each sample were
captured for each analysis. All immunofluorescence experiments
included no primary antibody, no secondary antibody, and isotype-
specific IgG1 controls to confirm specificity (data not shown).
For fluorescence microscopy, images were collected on an
Olympus Widefield BX51 upright microscope using a 20x/UPlanFLN
objective and captured using a Coolsnap HQ camera (Photometrics)
through MetaVue Software (Molecular Devices). Specific band pass
filter sets for DAPI, FITC, and tetramethylrhodaminoisothiocyanate
(TRITC) were used to prevent bleed-through from one channel to the
next. For confocal microscopy, images were collected using a Nikon
C1 confocal on an upright 90i microscope with a 60x/1.40 Plan Apo
objective and 3x confocal zoom. Images for DAPI, FITC, and Texas
red were excited with the 405, 488, and 543 nm laser lines,
respectively. Images were then processed and analysed using
Nikon EZ-C1 FreeViewer v3.3 software. For Delta Vision microscopy,
a Delta Vision restoration microscope (Applied Precision) 40x/0.85
UPlan Apo objective and Coolsnap (Photometrics) camera was
utilised. Raw images were deconvolved using the Softworx software;
maximum intensity projections of these deconvolved images are
shown.
Flow cytometry
Following trypsinisation, cells were left to recover in growth medium
for 1 h, washed twice in wash buffer (0.5% bovine serum albumin in
PBS) and 1×105 cells incubated with either phycoerythrin (PE)
conjugated or unconjugated primary antibody for 1 h, and then
washed three times with wash buffer. For an unconjugated antibody,
cells were additionally incubated with a species-specific fluorescein
isothiocyanate (FITC)-conjugated secondary antibody (1:200) (Dako)
for 45 min and then washed three times with wash buffer. For each
analysis, 100 000 cells were counted using a FACscan cytometer at a
flow rate less than 200 events per second.
VEGF-A detection
Enzyme-linked immunosorbent (ELISA) assays were performed using
the Quantikine human VEGF-A immunoassay (R&D Systems), accord-
ing to the manufacturer's protocol.Notch activation
Notch was activated either by ethylenediaminetetraacetic acid
(EDTA) (Rand et al., 2000) or recombinant Jagged-1. For EDTA
experiments, cells were stimulated for 15 min with 5 mM EDTA,
washed twice with basal medium, and left to recover for 24 h,
before isolation. For Notch activation using Jagged-1, recombinant
human Jagged-1/Fc chimera (1277-JG) (R&D Systems) was immobi-
lised on culture plates by incubating plates with a solution of Jagged-
1 (5 μg/ml) in PBS for 2 h at 37 °C. Control plates did not contain
recombinant human Jagged-1. For these experiments, HBMSCs were
seeded onto plates at low or high density and cultured for 24 h.
HBMSC differentiation assay
HBMSCs were induced to differentiate toward adipocyte, osteocyte,
or chondrocyte lineages using an MSC functional identification kit
(R&D Systems), according to the manufacturer's protocol, and then
cells were prepared for immunofluorescence analysis as previously
described using the antibodies provided. In addition, lipid droplets
were stained using boron-dipyrromethene (Bodipy) 493/503 (Invi-
trogen) and F-actin filaments stained using phalloidin.siRNA knockdown transfections
HBMSCs (5×105 cells), together with 3 μg small interfering RNAs
(siRNAs), were transfected by electroporation using a human
Nucleofector kit (Lonza), and cultured overnight in growth medium.
Validated siRNAs, which were functionally tested to provide ≥70%
target gene knockdown, were used for VEGF-A knockdown (Qiagen).
For Notch knockdowns, siRNAs for Notch1 (sc-36095), Notch2 (sc-
40135), and Notch3 (sc-37135) (Santa Cruz, USA) were employed,
with scrambled siRNA as a control (Qiagen).Immunoprecipitation analysis
Cell lysates were precleared using 10% (w/v) protein A-Sepharose (GE
Healthcare), and then precleared lysates were incubatedwith primary
antibody overnight at 4 °C. Immune complexes were isolated by
incubation with 10% (w/v) protein A-Sepharose for 2 h at 4 °C. Protein
A-Sepharosebeadswerewashed three times using ice-cold lysis buffer,
and then resuspended in NuPAGE gel loading buffer (Invitrogen).Endothelial functional tests
LDL uptake assay
ECs readily take up 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbo-
cyanine-labeled acetylated low density lipoprotein (Dil-Ac-LDL),
where the lipoprotein is degraded by lysosomes and fluorescent Dil
accumulates within intracellular membranes. Cells were incubated
with 10 μg/ml Dil-Ac-LDL (BT-906) (Biomedical Technologies Ltd) for
3 h at 37 °C, washed with PBS, fixed in 4% paraformaldehyde for
20 min, and then quenched in 0.2 M glycine for 20 min. Uptake of DiI-
ac-LDL was assessed by mounting coverslips using Prolong Gold
Antifade solution containing DAPI (Invitrogen) and examination using
an Olympus Widefield BX51 microscope.
Induction of vascular cell adhesion molecule-1 in response
to TNFα
Recombinant human tumour necrosis factor α (TNFα) (10 ng/ml)
(R&D Systems; 210-TA-010) was added to cells for 24 h, and then
cells were prepared for immunofluorescence analysis as previously
described.
249High stromal cell density induces vascular commitmentMatrigel tubule formation assay
A thin layer of growth factor-reduced Matrigel (BD Biosciences) was
used to coat round glass coverslips and allowed to set for 30 min at
37 °C. Cells (20 000) in 0.5% serum containing DMEM were seeded
onto the surface of Matrigel and incubated at 37 °C for up to 48 h to
allow tubule formation, and then prepared for immunofluorescence
analysis as previously described.
Chorioallantoic membrane (CAM) angiogenesis assay
Fertilized white chicken eggs were incubated for 6 days at 37.5 °C
and 43% humidity in a specialised egg incubator. To distinguish
implanted cells from chick cells on the CAM, implanted cells were
prelabeled with 10 μg/ml 1,1-dioctadecyl-3,3,3,3-tetramethylindo-
carbocyanine perchlorate DiI (Sigma-Aldrich) for 30 min at 37 °C,
seeded onto Matrigel-coated coverslips, and then left to adhere for
1 h. Eggs were cleaned with 70% ethanol and a square window was
cut into the shell with dissecting scissors to reveal the underlying
embryo and CAM blood vessels. The membrane covering the CAM
surface was carefully removed with forceps and coverslips were
implanted cell face down onto the CAM. The window was sealed
with transparent tape and the egg was returned to the incubator
for 48 h at 37.5 °C and 65% humidity, after which coverslips were
removed and prepared for immunofluorescence as previously
described.
Statistical analysis
In all quantitation experiments, results were expressed as the mean
standard deviation. Statistical differences between sets of data
were determined using a paired t test on SigmaPlot 8.0 software,
with Pb0.05 considered significant.
Acknowledgments
This work was funded by the Wellcome Trust [081215] and the
Medical Research Council [G0700712].
Appendix A. Supplementary data
Supplementary materials related to this article can be found online
at doi:10.1016/j.scr.2011.02.001.References
Al-Khaldi, A., Eliopoulos, N., Martineau, D., Lejeune, L., Lachapelle,
K., Galipeau, J., 2003. Postnatal bone marrow stromal cells elicit
a potent VEGF-dependent neoangiogenic response in vivo. Gene
Ther. 10, 621–629.
Aster, J.C., Simms, W.B., Zavala-Ruiz, Z., Patriub, V., North, C.L.,
Blacklow, S.C., 1999. The folding and structural integrity of the
first LIN-12 module of human Notch1 are calcium-dependent.
Biochemistry 38, 4736–4742.
Augello, A., De Bari, C., 2010. The regulation of differentiation in
mesenchymal stem cells. Hum. Gene Ther. 10, 1226–1238.
Bai, K., Huang, Y., Jia, X., Fan, Y., Wang, W., 2009. Endothelium
oriented differentiation of bone marrow mesenchymal stem cells
under chemical and mechanical stimulations. J. Biomech. 43,
1176–1181.
Ball, S.G., Shuttleworth, C.A., Kielty, C.M., 2004. Direct cell contact
influences bone marrow mesenchymal stem cell fate. Int. J.
Biochem. Cell Biol. 36, 714–727.
Ball, S.G., Shuttleworth, C.A., Kielty, C.M., 2007. Vascular
endothelial growth factor can signal through platelet-derived
growth factor receptors. J. Cell Biol. 177, 489–500.Bartosh, T.J., Ylöstalo, J.H., Mohammadipoor, A., Bazhanov, N.,
Coble, K., Claypool, K., Lee, R.H., Choi, H., Prockop, D.J., 2010.
Aggregation of human mesenchymal stromal cells (MSCs) into 3D
spheroids enhances their antiinflammatory properties. Proc. Natl
Acad. Sci. USA 107, 13724–13729.
Boulton, M.E., Cai, J., Grant, M.B., 2008. Gamma-Secretase: a
multifaceted regulator of angiogenesis. J. Cell. Mol. Med. 12,
781–795.
Casiraghi, F., Noris, M., Remuzzi, G., 2010. Immunomodulatory
effects of mesenchymal stromal cells in solid organ transplanta-
tion. Curr. Opin. Organ Transplant.
Chen, M.Y., Lie, P.C., Li, Z.L., Wei, X., 2009. Endothelial
differentiation of Wharton's jelly-derived mesenchymal stem
cells in comparison with bone marrow-derived mesenchymal
stem cells. Exp. Hematol. 37, 629–640.
Chung, N., Jee, B.K., Chae, S.W., Jeon, Y.W., Lee, K.H., Rha, H.K.,
2009. HOX gene analysis of endothelial cell differentiation in
human bone marrow-derived mesenchymal stem cells. Mol. Biol.
Rep. 36, 227–235.
Greenberg, J.I., Shields, D.J., Barillas, S.G., Acevedo, L.M., Murphy,
E., Huang, J., Scheppke, L., Stockmann, C., Johnson, R.S.,
Angle, N., Cheresh, D.A., 2008. A role for VEGF as a negative
regulator of pericyte function and vessel maturation. Nature 456,
809–813.
Gridley, T., 2007. Notch signaling in vascular development and
physiology. Development 134, 2709–2718.
Jakobsson, L., Franco, C.A., Bentley, K., Collins, R.T., Ponsioen, B.,
Aspalter, I.M., Rosewell, I., Busse, M., Thurston, G., Medvinsky,
A., Schulte-Merker, S., Gerhardt, H., 2010. Endothelial cells
dynamically compete for the tip cell position during angiogenic
sprouting. Nat. Cell Biol. 12, 943–953.
Kurpinski, K., Park, J., Thakar, R.G., Li, S., 2006. Regulation of
vascular smooth muscle cells and mesenchymal stem cells by
mechanical strain. Mol. Cell. Biomech. 3, 21–34.
Kurpinski, K., Lam, H., Chu, J., Wang, A., Kim, A., Tsay, E., Agrawal,
S., Schaffer, D., Li, S., 2010. TGF-beta and Notch signaling
mediate stem cell differentiation into smooth muscle cells. Stem
Cells 28, 734–742.
Lawson, N.D., Scheer, N., Pham, V.N., Kim, C.H., Chitnis, A.B.,
Campos-Ortega, J.A., Weinstein, B.M., 2001. Notch signaling is
required for arterial-venous differentiation during embryonic
vascular development. Development 128, 3675–3683.
Lee, R.H., Pulin, A.A., Seo, M.J., Kota, D.J., Ylostalo, J.,
Larson, B.L., Semprun-Prieto, L., Delafontaine, P., Prockop,
D.J., 2009a. Intravenous hMSCs improve myocardial infarction
in mice because cells embolized in lung are activated to
secrete the anti-inflammatory protein TSG-6. Cell Stem Cell
5, 54–63.
Lee, R.H., Pulin, A.A., Seo, M.J., Kota, D.J., Ylostalo, J., Larson,
B.L., Semprun-Prieto, L., Delafontaine, P., Prockop, D.J.,
2009b. Intravenous hMSCs improve myocardial infarction in
mice because cells embolized in lung are activated to secrete
the anti-inflammatory protein TSG-6. Cell Stem Cell 5, 54–63.
Lozito, T.P., Kuo, C.K., Taboas, J.M., Tuan, R.S., 2009. Human
mesenchymal stem cells express vascular cell phenotypes upon
interaction with endothelial cell matrix. J. Cell. Biochem. 107,
714–722.
McBeath, R., Pirone, D.M., Nelson, C.M., Bhadriraju, K., Chen, C.S.,
2004. Cell shape, cytoskeletal tension, and RhoA regulate stem
cell lineage commitment. Dev. Cell 6, 483–495.
Ohata, E., Tadokoro, R., Sato, Y., Saito, D., Takahashi, Y., 2009.
Notch signal is sufficient to direct an endothelial conversion from
non-endothelial somitic cells conveyed to the aortic region by
CXCR4. Dev. Biol. 335, 33–42.
Oswald, J., Boxberger, S., Jorgensen, B., Feldmann, S., Ehninger,
G., Bornhauser, M., Werner, C., 2004. Mesenchymal stem cells
can be differentiated into endothelial cells in vitro. Stem Cells
22, 377–384.
250 J.L. Whyte et al.Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas,
R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Crai, S.,
Marshak, D.R., 1999. Multilineage potential of adult human
mesenchymal stem cells. Science 284, 143–147.
Rand, M.D., Lindblom, A., Carlson, J., Villoutreix, B.O., Stenflo, J.,
1997. Calcium binding to tandem repeats of EGF-like modules.
Expression and characterization of the EGF-like modules of
human Notch-1 implicated in receptor-ligand interactions.
Protein Sci. 6, 2059–2071.
Rand, M.D., Grimm, L.M., Artavanis-Tsakonas, S., Patriub, V.,
Blacklow, S.C., Sklar, J., Aster, J.C., 2000. Calcium depletion
dissociates and activates heterodimeric notch receptors. Mol.
Cell. Biol. 20, 1825–1835.
Roukens, M.G., Alloul-Ramdhani, M., Baan, B., Kobayashi, K.,
Peterson-Maduro, J., van Dam, H., Schulte-Merker, S., Baker,
D.A., 2010. Control of endothelial sprouting by a Tel-CtBP
complex. Nat. Cell Biol. 12, 933–942.
Siekmann, A.F., Covassin, L., Lawson, N.D., 2008. Modulation of VEGF
signaling output by the Notch pathway. Bioessays 30, 303–313.
Wakitani, S., Saito, T., Caplan, A.I., 1995. Myogenic cells derived
from rat bone marrow mesenchymal stem cells exposed to 5-
azacytidine. Muscle Nerve 18, 1417–1426.Wu, X., Huang, L., Zhou, Q., Song, Y., Li, A., Jin, J., Cui, B., 2005a.
Mesenchymal stem cells participating in ex vivo endothelium
repair and its effect on vascular smooth muscle cells growth. Int.
J. Cardiol. 105, 274–282.
Wu, J., Iwata, F., Grass, J.A., Osborne, C.S., Elnitski, L., Fraser, P.,
Ohneda, O., Yamamoto, M., Bresnick, E.H., 2005b. Molecular
determinants of NOTCH4 transcription in vascular endothelium.
Mol. Cell. Biol. 25, 1458–1474.
Xu, J., Liu, X., Chen, J., Zacharek, A., Cui, X., Savant-Bhonsale, S.,
Liu, Z., Chopp, M., 2009. Simvastatin enhances bone marrow
stromal cell differentiation into endothelial cells via notch
signaling pathway. Am. J. Physiol. Cell Physiol. 296, C535–C543.
Yue,W.M., Liu,W., Bi, Y.W., He, X.P., Sun,W.Y., Pang, X.Y., Gu, X.H.,
Wang, X.P., 2008. Mesenchymal stem cells differentiate into an
endothelial phenotype, reduce neointimal formation, and enhance
endothelial function in a rat vein grafting model. Stem Cells Dev.
17, 785–793.
Zhang, G., Zhou, J., Fan, Q., Zheng, Z., Zhang, F., Liu, X., Hu, S.,
2008. Arterial-venous endothelial cell fate is related to vascular
endothelial growth factor and Notch status during human bone
mesenchymal stem cell differentiation. FEBS Lett. 582,
2957–2964.
